New Horizons and Perspectives in the Management of Chronic Hepatitis C

  • Jaswinder Singh Sodhi Department of Gastroenterology SKIMS
  • Shaheena Parveen
  • Riyaz u Saif
DOI: https://doi.org/10.33883/jms.v13i2.46
Keywords: HCV, interferons, Albinterferon, Belerofon, Interferon-lambda, Taribavirin, Telaprevir

Abstract

Hepatitis-C virus (HCV) infects 170 million people, 1 with worldwide sero prevalence of around 3%. Most of the patients develop chronic infection because the virus evades the host immune response in 55-85% of patients. Chronic HCV infection can lead to cirrhosis and hepato-cellular carcinoma. Complications of HCV-related cirrhosis are the leading indication for liver transplantation in United States and Europe... J Med Sci 2010;13(2):41-47

Downloads

Download data is not yet available.

Author Biographies

Jaswinder Singh Sodhi, Department of Gastroenterology SKIMS

D.M

Additional Professor

Shaheena Parveen

M.D

Riyaz u Saif

M.D, D.M

Published
2010-12-17
How to Cite
1.
Sodhi J, Parveen S, Saif R. New Horizons and Perspectives in the Management of Chronic Hepatitis C. jms [Internet]. 2010Dec.17 [cited 2026Oct.2];13(2):41-7. Available from: https://old.jmsskims.org/index.php/jms/article/view/46
Issue
Vol 13 No 2 (2010): July-December
Section
Review Articles

Most read articles by the same author(s)